efatutazone
Small moleculeexperimental
Clinical trial activity
12 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
7
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2006 (NCT00408434)
Timeline
Indications
Mechanism of action
PPARG agonist
Daichii Sankyo has suspended inhouse development in jan 2013, supports external development of the compound.
Chemistry & pharmacology
Loading structure…
SMILES
Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N- Mol. weight
- 502.6 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545280 ↗
- ChEMBLCHEMBL3545279 ↗
Also known as
- cs7017
- cs7017
- cs7017
- cs 7017
- cs-7017
- cs-7017
- cs-7017
- cs-7017
- efatutazone
- efatutazone
- efatutazone
- efatutazone
- efatutazone
- efatutazone hydrochloride
- efatutazone hydrochloride
- efatutazone hydrochloride
- rs5444
- rs 5444
- rs-5444
- rs-5444
- rs-5444
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02249949 | Phase 2 | Oct 1, 2014 | Daiichi Sankyo, Georgetown University, National Cancer Institute (NCI) |
| NCT02152137 | Phase 2 | Sep 1, 2014 | Daiichi Sankyo, Mayo Clinic, National Cancer Institute (NCI) |
| NCT01504490 | Phase 1 | Dec 1, 2011 | Daiichi Sankyo, Georgetown University |
| NCT01199068 | Phase 1 | Jun 1, 2010 | Daiichi Sankyo, ICON |
| NCT01101334 | Phase 2 | Mar 1, 2010 | Daiichi Sankyo |
| NCT01199055 | Phase 1 | Mar 1, 2010 | Daiichi Sankyo, ICON |
| NCT00967616 | Phase 2 | Sep 1, 2009 | Daiichi Sankyo |
| NCT00986440 | Phase 2 | Jul 1, 2009 | Daiichi Sankyo |
| NCT00881569 | Phase 1 | Mar 1, 2009 | Daiichi Sankyo |
| NCT00806286 | Phase 2 | Dec 1, 2008 | Daiichi Sankyo |
| NCT00603941 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2008 | Daiichi Sankyo |
| NCT00408434 | Phase 1 | Nov 1, 2006 | Daiichi Sankyo, Georgetown University |
Showing 12 of 12 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daiichi Sankyo | For profit | 12 | 9 | 2 | 2006 |
| Georgetown University | Academic/Hospital | 3 | 1 | 2 | 2006 |
| ICON | For profit | 2 | 0 | 1 | 2010 |
| National Cancer Institute (NCI) | Government | 2 | 2 | 1 | 2014 |
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2014 |
5 organizations
Page 1 / 1